CD163 and anti-neutrophil cytoplasmic antibody-associated vasculitis: This systematic review aimed to evaluate the evidence on urinary and serum biomarkers, specifically CD163, CD206, CD25, and MCP‐1, and combinations thereof for detecting disease activity in AAV.